Legend:

• Concept Types
  • target (clinical findings)
  • classification term
  • pathway-based classification term
  • clinical findings
  • multiple types disease
  • single disease
  • disease type

'Vascular Diseases'  (Integration tree)

Pathogenesis (traditional nomenclature)

• Genetic disorders of glycan synthesis (traditional nomenclature)

Pathogenesis (new nomenclature)

• Genetic disorders of glycan synthesis (new nomenclature)

Genetic disorders of glycan synthesis (by systems, signs and symptoms)

• Genetic disorders of glycan synthesis (by systems, signs and symptoms)
  • Diseases
    • Cardiovascular Diseases
      • Vascular Diseases
        • Aneurysm
          • Aneurysm, Dissecting
            • Ehlers-Danlos syndrome, type VI (GDGDB) (GDGDB) [PLOD1]
          • Aneurysm, Ruptured
            • Ehlers-Danlos syndrome, type VI (GDGDB) (GDGDB) [PLOD1]
            • Lysyl hydroxylase 3 deficiency (GDGDB) [PLOD3]
          • Intracranial Aneurysm
            • Lysyl hydroxylase 3 deficiency (GDGDB) [PLOD3]
          • Ehlers-Danlos syndrome, type VI (GDGDB) (GDGDB) [PLOD1]
          • Lysyl hydroxylase 3 deficiency (GDGDB) [PLOD3]
        • Embolism and Thrombosis
          • Thrombosis
            • Venous Thrombosis
              • PMM2-CDG (GDGDB) [PMM2]
                • PMM2-CDG, adult stable disability stage [PMM2]
              • ALG6-CDG (GDGDB) [ALG6]
              • PIGM-CDG [PIGM]
            • Paroxysmal nocturnal hemoglobinuria, somatic (SOMATIC MUTATION) (GDGDB) [PIGA]
            • PGM1-CDG [PGM1]
        • Cerebrovascular Disorders
          • PMM2-CDG (GDGDB) [PMM2]
            • PMM2-CDG, infantile multisystem stage [PMM2]
            • PMM2-CDG, late-infantile and childhood ataxia-intellectual disability stage [PMM2]
            • PMM2-CDG, adult stable disability stage [PMM2]
          • DPM3-CDG [DPM3]
          • PGM1-CDG [PGM1]
        • Hemostatic Disorders
          • Ehlers-Danlos Syndrome
            • Ehlers-Danlos syndrome, type VI (GDGDB) (GDGDB) [PLOD1]